Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Is ‘One to Watch’
Lexaria Bioscience Corp. has disruptive proprietary technology protected by a broad international patent portfolio The company has been issued 19 patents in the U.S., European Union and other countries, with more than 50 patents pending around the world Lexaria’s DehydraTECH technology has a vast worldwide, multi-billion-dollar total addressable market, including multiple rapid-growth segments like cannabinoid and noncombustible nicotine delivery The company has licensed its fat-soluble active molecule delivery technology to multiple established companies for use in their products Lexaria completed an uplisting to Nasdaq Capital Markets and an $11 million financing in January 2021 Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX)…